Search results for: 'cancer ad countir'
- Did you mean
- cancer ad country
- cancer ad countri
- Related search terms
- cancer vaccines market
- cancer immunotherapy global market
- cancer market size
- Cancer Vaccine Market - A Global and Regional Analysis: Focus on Vaccine Type, Technology Type, and Region - Analysis and Foreca
- cancer ad country
-
01 Aug 2018  |  Europe  |  Market Research
Analysis of Western European Molecular Imaging Market, Forecast to 2022
Improvements in Quantitation, New Clinical Applications, and Rising Prevalance of Cancer Keeps Market on the Upward Growth Curve
This study takes a look at the Western European molecular imaging industry. The geographic scope of the market includes the United Kingdom, Germany, Italy, Spain, France, Scandinavia, and Benelux. The market is expected to experience a compound annual growth rate (CAGR) of 4.5 percent during 2017 to 2022, primarily driven by the growing incidence o...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Nov 2021  |  Global  |  Technology Research
Targeted Immunotherapy in Oncology
Developments in Biotechnology Platforms Leading to Increasing Immuno-oncology Applications
This research service investigates technologies that propel the development of new targeted immunotherapies, particularly those that deliver therapeutic DNA and proteins. The top 3 growth opportunities focus on enhanced gene delivery systems for greater precision, the support of such systems through novel biotech platforms, and the affordability of...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Aug 2025  |  Global  |  Market Research
Oncology Biomarker Diagnostics, Global, 2024–2030
Regulatory Approvals, Companion Diagnostic Partnerships, and Precision Medicine are Driving Transformational Growth in the Industry, Fueled by Advances in Genomic Profiling and AI Integration
This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinfo...
$4,950.00 -
05 Oct 2018  |  North America  |  Market Research
Growth Opportunities in the Global Liquid Biopsy Market, 2018
Companies are Vying for a Higher Market Position in the Early Cancer Screening Market
Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Mar 2020  |  North America  |  Technology Research
Medical Devices in 2025: An AI Impact Analysis
Transforming Medical Imaging, Patient Monitoring, Ophthalmic and Cancer Diagnostics through Implementation of AI
Medical device manufacturers are increasingly incorporating artificial intelligence (AI) in their systems with the aim to better assist healthcare providers and also improve care provided to the patients. AI systems have the ability to acquire data, deploy logical rules for processing the data, generate reasonable solutions and automatically recogn...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Oct 2024  |  Global  |  Technology Research
Emerging Non-opioid Treatments for Pain Management
Advances in Non-opioid Therapies for Neuropathic, Migraine, and Cancer Pain Management Unlock New Growth Opportunities
The analysis explores cutting-edge advancements in non-opioid medications by delving into their mechanisms of action at a molecular scale, scrutinizing results from current clinical research initiatives, and appraising preparedness for and plausibility of regulatory approval. The considerations aim to highlight how these treatments may offer viable...
$4,950.00
Special Price $4,207.50 save 15 %
-
07 Nov 2016  |  North America  |  Market Research
Market Analysis of Premium European OEMs' ADAS and Automated Driving (AD) Strategies
Along with Level 3 and 4 Functions, Shared Mobility Portfolio to Play a Key Role in OEMs’ Future Business Models
While OEMs are racing towards achieving L4 and 5 automation features in their vehicles in developed markets such as NA and Europe, there will be major improvements in the ADAS sensors that will be used to achieve the desired features. Every OEM is working on a strategy that is different from others in terms of the level of automation desired. With ...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Dec 2025  |  Global  |  Technology Research
Emerging AI-Driven Platforms and Next-Generation Therapeutics: Innovations in Healthcare Analytics, Drug Discovery, Cancer Therapeutics, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision medicine. It highlights AI-driven platforms, advanced biologics, and digital health solutions that address critical challenges in accessibili...
$950.00 -
01 Feb 2013  |  Europe  |  Market Research
Analysis of the Global Pump Services Market
In an Uncertain Economic Environment, Value Added Services will have High Demand
The study analyses the global pump services market across various industries. With new pump projects on hold, there will be greater demand for pump services. Analysis is provided by type of pump service (MRO, installation and commissioning, decommissioning, and value added services). Geographic trends across four regions (North America, EMEA, APAC,...
$4,950.00
Special Price $3,712.50 save 25 %
-
04 Jul 2016  |  North America  |  Market Research
The Global Immuno-oncology Therapeutics Market—Checkpoint Inhibitors
The Next Generation of Cancer Therapies
Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...
$8,000.00
Special Price $6,000.00 save 25 %